Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution

被引:119
|
作者
Natsugoe, S. [1 ]
Okumura, H. [1 ]
Matsumoto, M. [1 ]
Uchikado, Y. [1 ]
Setoyama, T. [1 ]
Yokomakura, N. [1 ]
Ishigami, S. [1 ]
Owaki, T. [1 ]
Aikou, T. [1 ]
机构
[1] Kagoshima Univ, Sch Med, Dept Surg Oncol & Digest Surg, Kagoshima 890, Japan
关键词
chemoradiation therapy; esophageal cancer; randomized controlled study;
D O I
10.1111/j.1442-2050.2006.00615.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The purpose of the present study was to compare the clinical results between preoperative chemoradiotherapy followed by surgery (CRT group) and surgery alone (Surgery group) by a randomized controlled study. Twenty-two patients were assigned to the CRT group and 23 to the Surgery group. A total radiation dose of 40 Gy was applied and in the same period, intravenous chemotherapy was performed using cisplatin (7 mg over 2 h) and 5-fluorouracil (5-FU; 350 mg over 24 h). Surgical treatment was performed in 20 patients in the CRT group except for two patients with bone metastasis after CRT. According to histological effects of primary tumors, the number of patient with Grades 1, 2 and 3 was 11, 7 and 3, respectively. Frequency of lymphatic and venous invasion was significantly lower in the CRT group than in the Surgery group. The 5-year survival rate was 57% in the CRT group and 41% in the Surgery group (P = 0.58). According to the histological effect in the CRT group, 5-year survival was 30% for Grade 1, 83% for Grade 2 and 100% for Grade 3 (P = 0.0069). This randomized trial did not demonstrate a statistically significant survival difference between the CRT group and the Surgery group.
引用
收藏
页码:468 / 472
页数:5
相关论文
共 50 条
  • [31] Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial
    Boonstra, Jurjen J.
    Kok, Tjebbe C.
    Wijnhoven, Bas P. L.
    van Heijl, Mark
    Henegouwen, Mark I. van Berge
    ten Kate, Fiebo J. W.
    Siersema, Peter D.
    Dinjens, Winand N. M.
    van Lanschot, Jan J. B.
    Tilanus, Hugo W.
    van der Gaast, Ate
    BMC CANCER, 2011, 11
  • [32] Chemotherapy followed by surgery versus surgery alone in patients with resectable oesophageal squamous cell carcinoma: Long-term results of a randomized controlled trial
    Jurjen J Boonstra
    Tjebbe C Kok
    Bas PL Wijnhoven
    Mark van Heijl
    Mark I van Berge Henegouwen
    Fiebo JW ten Kate
    Peter D Siersema
    Winand NM Dinjens
    Jan JB van Lanschot
    Hugo W Tilanus
    Ate van der Gaast
    BMC Cancer, 11
  • [33] A Phase II/III Randomized Controlled Trial of Adjuvant Radiotherapy, Concurrent Chemoradiotherapy after Surgery Versus Surgery Alone in Patients with Stage IIB-III Esophageal Squamous Cell Carcinoma
    Ni, W.
    Xiao, Z.
    Zhou, Z.
    Wang, X.
    Chen, D.
    Qinfu, F.
    Liang, J.
    Lv, J.
    Bi, N.
    Deng, L.
    Zhang, T.
    Wang, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E193 - E193
  • [34] Cost-effectiveness analysis of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced esophageal squamous cell carcinoma based on the NEOCRTEC5010 trial
    Zhan, Mei
    Zheng, Hanrui
    Yang, Yu
    Xu, Ting
    Li, Qiu
    RADIOTHERAPY AND ONCOLOGY, 2019, 141 : 27 - 32
  • [35] Evaluation of Neoadjuvant Chemoradiotherapy Followed by Surgery for Borderline Resectable Esophageal Squamous Cell Carcinoma
    Hirohata, Ryosuke
    Hamai, Yoichi
    Hihara, Jun
    Emi, Manabu
    Kurokawa, Tomoaki
    Yoshikawa, Toru
    Ohsawa, Manato
    Kitasaki, Nao
    Okada, Morihito
    WORLD JOURNAL OF SURGERY, 2022, 46 (08) : 1934 - 1943
  • [36] Evaluation of Neoadjuvant Chemoradiotherapy Followed by Surgery for Borderline Resectable Esophageal Squamous Cell Carcinoma
    Ryosuke Hirohata
    Yoichi Hamai
    Jun Hihara
    Manabu Emi
    Tomoaki Kurokawa
    Toru Yoshikawa
    Manato Ohsawa
    Nao Kitasaki
    Morihito Okada
    World Journal of Surgery, 2022, 46 : 1934 - 1943
  • [37] Neoadjuvant Chemotherapy Followed by Surgery Versus Surgery Alone for Colorectal Cancer Meta-analysis of Randomized Controlled Trials
    Huang, Lei
    Li, Tuan-Jie
    Zhang, Jian-Wen
    Liu, Sha
    Fu, Bin-Sheng
    Liu, Wei
    MEDICINE, 2014, 93 (28) : e231
  • [38] Concurrent chemoradiotherapy alone is feasible for esophageal squamous cell carcinoma patients not suitable for surgery
    Chen, Yongshun
    Wang, Jun
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (01) : 182 - 182
  • [39] Surgery alone versus neoadjuvant chemoradiotherapy followed by surgery in patients with stage T2N0M0 esophageal cancer
    Lin, Yan
    Wang, Shou-Feng
    Liang, Huan-Wei
    Liu, Yang
    Huang, Wei
    Pan, Xin-Bin
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [40] A phase III clinical trial of neoadjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of the esophagus.
    Yang, Hong
    Fu, Jianhua
    Liu, Mengzhong
    Fang, Wenteo
    Wang, Jiaming
    Chen, Yuping
    Chen, Zhijian
    Zhu, Chengchu
    Xiang, Jiaqing
    Yang, Huanjun
    Yu, Zhengtao
    Pang, Qingsong
    Mao, Weimin
    Zheng, Xiao
    Han, Yongtao
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)